Business

January 21, 2014 11:52 AM

Durham's Argos Therapeutics looking to raise up to $60 million with IPO

Argos Therapeutics is hoping that Wall Street will value its business in the neighborhood of $250 million. The Durham drug-development company provided more details Tuesday in its latest filing with the Securities and Exchange Commission.

Related content

Comments

Videos

More Videos

Transgender CEO speaks out on NC's HB2 02:49

Transgender CEO speaks out on NC's HB2

Two-year-old girl from Brazil sees her mother for the first time thanks to surgery 02:34

Two-year-old girl from Brazil sees her mother for the first time thanks to surgery

Inaugural Delta RDU to Paris nonstop flight 00:54

Inaugural Delta RDU to Paris nonstop flight

Sights & sounds of a Cuban tobacco harvest 01:04

Sights & sounds of a Cuban tobacco harvest

Sifting Southern history 02:03

Sifting Southern history

HB2 fallout impacts High Point Furniture Market 00:56

HB2 fallout impacts High Point Furniture Market

MetLife opens new Global Technolgy Campus in Cary, NC 01:16

MetLife opens new Global Technolgy Campus in Cary, NC

Solar Farm under construction in Robeson County 00:54

Solar Farm under construction in Robeson County

Inside Counter Culture Coffee's new headquarters 01:41

Inside Counter Culture Coffee's new headquarters

Share Video

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos